May 3, 2016
Date: Friday, 13th May, 2016
Time: 4:30pm Networking, Presentation 5pm followed by drinks and nibbles.
Venue: SBS Reception Lounge (Common Room), School of Biological Sciences.
Guest Speaker: This month we welcome Distinguished Professor Bill Denny speaking on the topic: Hypoxia-activated prodrugs for cancer: from concept to clinic with PR-104
Bill Denny will cover the story of PR-104, the hypoxia-activated prodrug for cancer: from concept through refinement to clinical candidate and clinical trial (the latter with the UniServices’ startup company Proacta Inc, a story in itself). What was learned, what went wrong and its current status.
Distinguished Professor Bill Denny is Director of the Auckland Cancer Society Research Centre at the University of Auckland, where he also leads medicinal chemistry research. He has led or been closely involved in the design and development of twelve new drugs brought to clinical trials, in collaboration with different commercial partners, and was a scientific co-founder of the start-up companies Proacta Inc and Pathway Therapeutics. In 2014 he received the American Chemical Society’s Division of Medicinal Chemistry Award for outstanding contributions to medicinal chemistry, the first such award given outside the United States in more than 30 years.
Please reply YES in the subject line by email to email@example.com
Date and time
4.30-6.30 pm drinks and canapés (for 5.00 pm presentation), Friday 13th May
Reception Lounge, at the IIB and SBS entrance to the Thomas Building, 3a Symonds St (see map).
University is well serviced by bus routes, and car parking is available under the University of Auckland Business School (the Owen G Glenn Building) on Grafton Rd.